• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盾鼻蛇毒液中凝血酶原激活剂的纯化及特性

Purification and properties of a prothrombin activator from the venom of Notechis scutatus scutatus.

作者信息

Tans G, Govers-Riemslag J W, van Rijn J L, Rosing J

出版信息

J Biol Chem. 1985 Aug 5;260(16):9366-72.

PMID:3894355
Abstract

The prothrombin activator present in the venom of the mainland tiger snake (Notechis scutatus scutatus) was purified to homogeneity by gel chromatography on Sephadex G-200 followed by ion-exchange chromatography on SP-Sephadex. The venom activator has an apparent molecular weight of 54,000. It consists of a heavy chain (Mr = 32,000) and a light chain (Mr = 23,000) held together by one or more disulfide bridges. The active site is located at the heavy chain region of the molecule. The venom activator contains 8 gamma-carboxyglutamic acid residues/molecule. Gel electrophoretic analysis of prothrombin activation indicates that the venom activator is capable of cleaving both the Arg 274-Thr 275 and Arg 323-Ile 324 bonds of bovine prothrombin. The order of bond cleavage appears to be random since prethrombin-2 and meizothrombin occur as intermediates during prothrombin activation. Prothrombin activation by the venom activator alone is very slow. This is explained by the unfavorable kinetic parameters for the reaction (Km for prothrombin = 105 microM, Vmax = 0.0025 nmol of prothrombin activated per min/microgram of venom activator). Phospholipids plus Ca2+ and Factor Va greatly stimulate venom-catalyzed prothrombin activation. In the presence of 50 microM phospholipid vesicles composed of 20 mol % phosphatidylserine and 80 mol % phosphatidylcholine, the Km drops to 0.2 microM, whereas there is hardly any effect on the Vmax. Factor Va causes a 3,500-fold increase of the Vmax (8.35 nmol of prothrombin activated per min/microgram of venom activator) and a 10-fold decrease of the Km (9.5 microM). The most favorable kinetic parameters are observed in the presence of both 50 microM phospholipid and Factor Va (Km = 0.16 microM, Vmax = 27.9 nmol of prothrombin activated per min/microgram of venom activator). These changes of the kinetic parameters explain the stimulatory effects of Factor Va and phospholipid on venom-catalyzed prothrombin activation. The venom activator slowly converts the Factor Xa-specific chromogenic substrates CH3SO2-D-leucyl-glycyl-L-arginine-p-nitroanilide and N-benzoyl-L-isoleucyl-L-glutamyl-(piperidyl)-glycyl-L-arginyl-p-nitroani lide hydrochloride. Factor Va causes a 7-fold stimulation of chromogenic substrate conversion by the venom activator. This stimulation appears to be the result of the formation of a tight 1:1 complex between the venom activator and Factor Va.

摘要

通过在葡聚糖凝胶G - 200上进行凝胶色谱,随后在SP - 葡聚糖凝胶上进行离子交换色谱,将大陆虎蛇(盾鼻蛇盾鼻亚种,Notechis scutatus scutatus)毒液中的凝血酶原激活剂纯化至同质。该毒液激活剂的表观分子量为54,000。它由一条重链(Mr = 32,000)和一条轻链(Mr = 23,000)通过一个或多个二硫键连接而成。活性位点位于分子的重链区域。该毒液激活剂每分子含有8个γ - 羧基谷氨酸残基。凝血酶原激活的凝胶电泳分析表明,该毒液激活剂能够切割牛凝血酶原的Arg 274 - Thr 275和Arg 323 - Ile 324键。键切割顺序似乎是随机的,因为凝血酶原-2和中凝血酶在凝血酶原激活过程中作为中间体出现。仅毒液激活剂对凝血酶原的激活非常缓慢。这可以通过该反应不利的动力学参数来解释(凝血酶原的Km = 105 microM,Vmax = 每分钟每微克毒液激活剂激活0.0025 nmol凝血酶原)。磷脂加Ca2 +和因子Va极大地刺激毒液催化的凝血酶原激活。在由20摩尔%磷脂酰丝氨酸和80摩尔%磷脂酰胆碱组成的50 microM磷脂囊泡存在下,Km降至0.2 microM,而对Vmax几乎没有影响。因子Va使Vmax增加3500倍(每分钟每微克毒液激活剂激活8.35 nmol凝血酶原),Km降低10倍(9.5 microM)。在同时存在50 microM磷脂和因子Va的情况下观察到最有利的动力学参数(Km = 0.16 microM,Vmax = 每分钟每微克毒液激活剂激活27.9 nmol凝血酶原)。动力学参数的这些变化解释了因子Va和磷脂对毒液催化的凝血酶原激活的刺激作用。该毒液激活剂缓慢转化因子Xa特异性显色底物CH3SO2 - D - 亮氨酰 - 甘氨酰 - L - 精氨酸 - 对硝基苯胺和N - 苯甲酰 - L - 异亮氨酰 - L - 谷氨酰 - (哌啶基) - 甘氨酰 - L - 精氨酰 - 对硝基苯胺盐酸盐。因子Va使毒液激活剂对显色底物的转化增加7倍。这种刺激似乎是毒液激活剂与因子Va之间形成紧密1:1复合物的结果。

相似文献

1
Purification and properties of a prothrombin activator from the venom of Notechis scutatus scutatus.盾鼻蛇毒液中凝血酶原激活剂的纯化及特性
J Biol Chem. 1985 Aug 5;260(16):9366-72.
2
Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake).由盾尖吻蛇(太攀蛇)毒液中的一种激活剂引发的凝血酶原激活。
J Biol Chem. 1986 Oct 5;261(28):13258-67.
3
Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.由中亚眼镜蛇毒液中纯化的激活剂对牛凝血因子V的激活作用。
Toxicon. 1992 Sep;30(9):1065-79. doi: 10.1016/0041-0101(92)90052-7.
4
Structural and functional characterization of a prothrombin activator from the venom of Bothrops neuwiedi.巴西矛头蝮蛇毒凝血酶原激活剂的结构与功能特性
Biochim Biophys Acta. 1987 Dec 18;916(3):388-401. doi: 10.1016/0167-4838(87)90185-3.
5
Platelet procoagulant properties studied with snake venom prothrombin activators.用蛇毒凝血酶原激活剂研究血小板促凝特性。
Thromb Haemost. 1987 Jun 3;57(3):349-55.
6
The role of phospholipids and factor Va in the prothrombinase complex.磷脂和因子Va在凝血酶原酶复合物中的作用。
J Biol Chem. 1980 Jan 10;255(1):274-83.
7
Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid.在无磷脂情况下,关于因子Va在因子Xa催化凝血酶原、1.2片段-凝血酶原-2及丹磺酰-L-谷氨酰-甘氨酰-L-精氨酸-前凝血酶原激活中作用的研究。
J Biol Chem. 1990 Jun 25;265(18):10497-505.
8
Amino acid sequence of trocarin, a prothrombin activator from Tropidechis carinatus venom: its structural similarity to coagulation factor Xa.三棱剑蛇毒中凝血酶原激活剂trocarin的氨基酸序列:其与凝血因子Xa的结构相似性。
Blood. 1999 Jul 15;94(2):621-31.
9
Preparation and properties of derivatives of bovine factor X and factor Xa from which the gamma-carboxyglutamic acid containing domain has been removed.去除了含γ-羧基谷氨酸结构域的牛凝血因子X及凝血因子Xa衍生物的制备与性质
J Biol Chem. 1986 Mar 25;261(9):4015-23.
10
Pseutarin C, a prothrombin activator from Pseudonaja textilis venom: its structural and functional similarity to mammalian coagulation factor Xa-Va complex.伪眼镜蛇毒素C,一种来自澳太拉西亚虎蛇毒液的凝血酶原激活剂:它与哺乳动物凝血因子Xa-Va复合物的结构和功能相似性。
Thromb Haemost. 2002 Oct;88(4):611-9.

引用本文的文献

1
Age Is Just a Number: Ontogenetic Conservation in Activation of Blood Clotting Factors VII, X, and XII by Caucasus Blunt-Nosed Viper () Venoms.年龄只是一个数字:高加索钝鼻蝰蛇毒液激活凝血因子VII、X和XII过程中的个体发育保守性
Toxins (Basel). 2024 Dec 2;16(12):520. doi: 10.3390/toxins16120520.
2
From Venom to Vein: Factor VII Activation as a Major Pathophysiological Target for Procoagulant Australian Elapid Snake Venoms.从毒液到静脉:凝血因子 VII 激活作为澳大利亚致栓型毒蛇毒液的主要病理生理靶点。
Toxins (Basel). 2024 Oct 6;16(10):430. doi: 10.3390/toxins16100430.
3
Exploring the Diversity and Function of Serine Proteases in Toxicofera Reptile Venoms: A Comprehensive Overview.
探索毒蜥目爬行动物毒液中丝氨酸蛋白酶的多样性和功能:全面概述。
Toxins (Basel). 2024 Oct 3;16(10):428. doi: 10.3390/toxins16100428.
4
A Clot Twist: Extreme Variation in Coagulotoxicity Mechanisms in Mexican Neotropical Rattlesnake Venoms.一个血栓的扭曲:墨西哥新热带响尾蛇毒液中凝血毒性机制的极端变化。
Front Immunol. 2021 Mar 11;12:612846. doi: 10.3389/fimmu.2021.612846. eCollection 2021.
5
In vivo evaluation of homeostatic effects of Echis carinatus snake venom in Iran.伊朗地区关于圆斑蝰蛇蛇毒体内平衡作用的评价。
J Venom Anim Toxins Incl Trop Dis. 2013 Feb 27;19(1):3. doi: 10.1186/1678-9199-19-3.
6
Structure-function and regulation of ADAMTS-13 protease.ADAMTS-13 蛋白酶的结构-功能与调控。
J Thromb Haemost. 2013 Jun;11 Suppl 1(0 1):11-23. doi: 10.1111/jth.12221.
7
Notecarin D binds human factor V and factor Va with high affinity in the absence of membranes.无膜条件下,野尻霉素 D 以高亲和力结合人因子 V 和因子 Va。
J Biol Chem. 2011 Nov 4;286(44):38286-38297. doi: 10.1074/jbc.M111.247122. Epub 2011 Sep 12.
8
Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa.来自蛇毒的D组凝血酶原激活剂是哺乳动物凝血因子Xa的结构同源物。
Biochem J. 2003 Feb 1;369(Pt 3):635-42. doi: 10.1042/BJ20020889.
9
A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning.一种来自红口蝮(干燥雅拉卡蝰蛇)蛇毒的凝血酶原激活剂:特性与分子克隆
Biochem J. 2003 Jan 1;369(Pt 1):129-39. doi: 10.1042/BJ20020449.
10
Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.口服抗凝剂对血栓形成素质患者血液中止血系统激活的抑制作用。
J Clin Invest. 1987 Dec;80(6):1535-44. doi: 10.1172/JCI113239.